Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Precision medicine diagnostic commercialisation platform and data analytics
Diaceutics is a data analytics and services company providing pharmaceutical and biotechnology clients with an end-to-end solution for the commercialisation of precision medicine diagnostics. The company integrates real-world diagnostic testing data from a global network of over 52,000 laboratories, applying machine…
Rapid point-of-care antibiotic susceptibility testing for antimicrobial resistance
Microplate Dx is a diagnostics biotechnology company developing a rapid antibiotic susceptibility testing platform for use at the point of care. Its biosensor technology uses hydrogel-modified electrodes loaded with antibiotics to determine the most effective treatment for a patient's bacterial infection in under one…
Molecular diagnostic assay development for oncology biomarkers
APIS Assay Technologies is a molecular diagnostics company developing and commercialising genomic assays for oncology and personalised medicine. The company combines an in-house biomarker research programme with contract assay development services, using PCR, digital PCR, and multi-omics platforms to translate…
Veterinary diagnostic instruments, reference laboratory and imaging services
IDEXX Laboratories Limited is the UK subsidiary of IDEXX Laboratories, Inc., a global leader in veterinary diagnostics. Operating from Wetherby, North Yorkshire, the company provides in-clinic diagnostic analysers and consumables, a UKAS-accredited reference laboratory spanning biochemistry, haematology, microbiology,…
Host-response biomarker test to rapidly diagnose sepsis
Profionics is a diagnostics company developing a precision molecular test for rapid sepsis detection. Its platform analyses 52 patient-invariant biomarkers spanning inflammatory, metabolic, and adaptive immune pathways, using transcriptomics, metabolomics, and lipidomics in combination with artificial intelligence.…
T-cell immune profiling diagnostics and immunology research reagents
Virax Biolabs develops diagnostic tests that measure T-cell immune responses to viral infections. Its lead assay focuses on post-acute infection syndromes, including long COVID, and is intended to help characterise patients' cellular immune responses. The company also supplies immunology research reagents, including…
Rapid genomic diagnostic device for sepsis and bacterial infections
GenomeKey is a biotechnology company developing an in vitro diagnostic device that uses whole genome sequencing and machine learning to identify bacteria and their antimicrobial resistance profiles directly from patient blood within hours. The device targets sepsis, where current culture-based diagnostics take 24 to…
Applied genetics and genomics services and distribution for DNA testing
Biosecure ID is a contract research organisation providing professional services and integrated workflow solutions for applied genetics and genomics testing. The company supports academic, clinical, and forensic laboratories with workflow validation, implementation, and turnkey project delivery across NGS, STR…
Instruments, reagents, and diagnostics for life science research and clinical laboratories
Bio-Rad Laboratories Limited is the UK subsidiary of Bio-Rad Laboratories, Inc., a global manufacturer of instruments and reagents for life science research and clinical diagnostics. Its life science portfolio spans electrophoresis, PCR and digital droplet PCR, flow cytometry, protein purification, multiplex…
National genomics research and NHS whole genome sequencing
Genomics England is a government-owned organisation that partners with the NHS to deliver whole genome sequencing diagnostics and advance genomic medicine in the UK. It operates the National Genomic Research Library, providing approved researchers with access to linked genomic and clinical data to identify the causes…
Multiomics blood-based platform for early-stage cancer detection
Freenome is a biotechnology company developing blood-based early cancer detection tests using a multiomics platform that combines tumour and non-tumour biological signals with machine learning. The UK subsidiary, based in Nottingham, holds the autoantibody immunodiagnostic technology and cancer detection pipeline…
Point-of-care molecular diagnostic platform for rapid infectious disease detection
Diagnostics for the Real World (Europe) is a Cambridge University spin-out developing and commercialising a fully automated point-of-care molecular diagnostic system for rapid detection of infectious diseases. Using isothermal nucleic acid amplification, the platform delivers sample-in-result-out testing without…
Rapid point-of-care molecular diagnostics for infectious disease
Llusern Scientific is a diagnostics company developing portable, rapid molecular diagnostic systems for use at the point of care. Using isothermal amplification technology, the company's platform identifies bacterial pathogens directly from patient samples without laboratory infrastructure, delivering results within…
Small molecule theranostics to improve transplant outcomes
Kairos Biotech is an early-stage biotechnology company developing proprietary small molecules and nanoscale-engineered binders for application in transplant diagnostics and targeted immunotherapy. The company's theranostic approach identifies molecules capable of detecting donor-specific alloreactivity and further…
High-density e-textile sensors for AI-powered cardiac diagnostics
Polytecks is a University of Cambridge spin-out developing wearable, textile-based sensors for high-resolution bioelectrical mapping. Patented electrode arrays capture heart signals at far higher density than standard ECGs, with AI transforming the data into detailed cardiac maps within minutes to support earlier…
Breath biomarker research instruments and analytical services
Owlstone Medical Limited is a diagnostics company developing breath-based biomarker tools and laboratory services for clinical and life science research. Its sampling instruments collect exhaled breath for analysis of volatile organic compounds, which may reflect metabolic activity and disease processes. The company…
Fluorescent nanoparticle probes and antibody conjugation reagents
Stream Bio is a developer and manufacturer of fluorescent conjugated polymer nanoparticles for biological imaging and diagnostic research. Its visible and near-infrared probes support microscopy, flow cytometry, immunoassays and lateral-flow test development. The company supplies streptavidin-linked reagents and…
High-affinity sheep monoclonal antibodies for clinical diagnostic testing
Bioventix is a UK biotechnology company that creates, manufactures and supplies high-affinity sheep monoclonal antibodies for clinical diagnostic applications, particularly where conventional antibodies have failed to detect low-concentration or difficult targets. Its antibodies are supplied to major multinational in…
Point-of-care pharmacogenetic testing platform for emergency healthcare
Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in time-critical emergency care. Its flagship products, developed and validated with NHS partners, include a neonatal test preventing…
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…